1.Advances in research of let-7 in cancer
Xiuming ZHU ; Lingjiao WU ; Fusheng WU
Journal of International Oncology 2011;38(2):89-92
Let-7 is one of the most widely studied in miRNAs at present. let-7 can inhibit cell proliferation, promote cell differentiation and apoptosis, etc. Reduced expression of let-7 in different human tumor tissues or cells is accompanied by the changes of its target genes expression, which suggests that let-7 is closely linked to cancer.
2.Effect of Human Immunoglobulin for Intravenous Injection in the treatment and intervention of neonatal infectious pneumonia
Lingjiao ZHU ; Lingfang ZHAO ; Lingzi ZHANG
Chinese Journal of Biochemical Pharmaceutics 2017;37(8):388-389
Objective To discuss the effect of Human Immunoglobulin for Intravenous Injection in the treatment of neonatal pneumonia treatment and intervention. Methods 100 cases of newborns in our hospital from July 2015 to 2016 to receive the treatment of infectious pneumonia patients, and were randomly divided into control group and observation group, 50 cases in each group. The control group used routine treatment, the observation group on the basis of intravenous immunoglobulin and take corresponding nursing measures. The treatment were compared between the two groups of the total efficiency of disappearance of hospitalization time and pulmonary rales and difficulty breathing time. Results In the control group than the treatment in the observation group the total efficiency significantly comparison between the two groups of children have statistical significance(P<0.05); disappeared in the observation group hospitalization time and pulmonary rales and dyspnea was significantly better on time According to the group, there were significant differences between the two groups have statistical significance(P<0.05). Conclusion The use of Human Immunoglobulin for Intravenous Injection on the treatment of neonatal pneumonia, can effectively promote the treatment efficiency, and is helpful to the patient's recovery, worthy of promotion in clinical use.
3.HCV Infection in Maintenance Hemodialysis Patients:Investigation and Analysis
Guoyou WU ; Aizhou ZHUANG ; Jie ZHU ; Lingjiao WU
Chinese Journal of Nosocomiology 2006;0(12):-
OBJECTIVE To investigate the HCV infection and the distribution condition of HCV subtype in maintenance hemodialysis patients.METHODS A total of 210 cases with maintenance hemodialysis were recruited into this study.Serum samples were tested for anti-HCV antibodies using ELISA and HCV RNA by RT-PCR.At the same time,samples with anti-HCV IgM positive were identified for their subtype.RESULTS In all cases,91 cases(43.3%) were anti-HCV IgM positive,87 cases(41.4%) were anti-HCV IgG positive,and 105 cases(50.0%) were HCV-RNA positive.Eighty one cases(38.6%) were positive for all HCV infection markers,and 117 cases(55.7%) were positive for at least one marker.Compared that of cases with negative all HCV infection markers,the levels of ALT,AST,LDH and ?-GT in maintenance hemodialysis patients whose at least one marker was positive were significantly higher.Of 91 cases with positive anti-HCV IgM,55 cases(64.4%) were with type 1,9 cases(9.8%) with type 2,13 cases(14.2%) with type 3,and 7 cases(7.6%) with type 6.In addition,3 cases(3.2%) with types 1+6,and 4 cases(4.3%) were with types 1+3.CONCLUSIONS The infectious ratio of HCV in maintenance hemodialysis patients is high,particularly that of type 1 HCV is the highest.
4.Vicissitudes of Resistance to Imipenem in Gram-negative Bacilli
Liming ZHANG ; Shanshan ZHU ; Lingjiao GUO ; Ying ZHANG ; Xianjun CHEN
Chinese Journal of Nosocomiology 2006;0(12):-
OBJECTIVE To investigate the vicissitudes of resistance to imipenem in Gram-negative bacilli isolated from clinical specimens.METHODS Gram-negative bacilli were isolated from various clinical specimens in our hosptial from Jan 2004 to Jan 2008.The identification and antimicrobiol susceptiblity test was determined by VITEK-AMS full automated microbiology analyzer.RESULTS A total of 6983 strains of Gram-negative bacilli were isolated,including 92 species and 2986 isolates of Enterobacteriaceae and 3961 isolates of non-fermenters,accounted for 42.8% and 56.7%,respectively.The resistant rate of Enterobacteriaceae to imipenem was lower than 1.0%.The resistant rates of Stenotrophomonas maltophilia,Burkholderia cepacia,Chryseobacterium meningosepticum,Pseudomonas aeruginosaand Acinetobacter baumannii to imipenem were 98.4%,97.0%,98.2%,70.1% and 47.5%,respectively.CONCLUSIONS Non-fermenters are predominant pathogens.Imipenem has high antimicrobial activity to Enterobacteriaceae in invro,but not to non-fermenters.The resistant rates of P.aeruginosa and A.baumannii to imipenem are increasing gradually.